Cargando…
ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination
The immune mechanism leading to the generation of protective antibody responses following influenza trivalent inactivated vaccine (TIV) vaccinations remains largely uncharacterized. We recently reported that TIV vaccination induced a transient increase of circulating ICOS(+)PD-1(+)CXCR3(+) T follicu...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882544/ https://www.ncbi.nlm.nih.gov/pubmed/27231124 http://dx.doi.org/10.1038/srep26494 |
_version_ | 1782434131084312576 |
---|---|
author | Bentebibel, Salah-Eddine Khurana, Surender Schmitt, Nathalie Kurup, Parvathi Mueller, Cynthia Obermoser, Gerlinde Palucka, A. Karolina Albrecht, Randy A. Garcia-Sastre, Adolfo Golding, Hana Ueno, Hideki |
author_facet | Bentebibel, Salah-Eddine Khurana, Surender Schmitt, Nathalie Kurup, Parvathi Mueller, Cynthia Obermoser, Gerlinde Palucka, A. Karolina Albrecht, Randy A. Garcia-Sastre, Adolfo Golding, Hana Ueno, Hideki |
author_sort | Bentebibel, Salah-Eddine |
collection | PubMed |
description | The immune mechanism leading to the generation of protective antibody responses following influenza trivalent inactivated vaccine (TIV) vaccinations remains largely uncharacterized. We recently reported that TIV vaccination induced a transient increase of circulating ICOS(+)PD-1(+)CXCR3(+) T follicular helper (cTfh) cells in blood, which positively correlated with the induction of protective antibody responses measured at day 28. However, whether and how these T cells directly contribute to antibody response remains unclear. In this study, we analyzed the changes after TIV vaccination in the amount and the avidity of the polyclonal antibodies specific for the HA1 subunit of the pandemic H1N1 virus, and analyzed the correlation with the increase of ICOS(+)PD-1(+)CXCR3(+) cTfh cells. We found that both the amount and the avidity of specific antibodies rapidly increased during the first 7 days after TIV. Importantly, the increase of ICOS(+)PD-1(+)CXCR3(+) cTfh cells strongly correlated with the increase in the avidity of antibodies, particularly in subjects who did not have high affinity antibodies at baseline. We propose that ICOS(+)PD-1(+)CXCR3(+) Tfh cells directly contribute to the generation of high-avidity antibodies after TIV vaccinations by selectively interacting with high affinity B cells at extrafollicular sites. |
format | Online Article Text |
id | pubmed-4882544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48825442016-06-08 ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination Bentebibel, Salah-Eddine Khurana, Surender Schmitt, Nathalie Kurup, Parvathi Mueller, Cynthia Obermoser, Gerlinde Palucka, A. Karolina Albrecht, Randy A. Garcia-Sastre, Adolfo Golding, Hana Ueno, Hideki Sci Rep Article The immune mechanism leading to the generation of protective antibody responses following influenza trivalent inactivated vaccine (TIV) vaccinations remains largely uncharacterized. We recently reported that TIV vaccination induced a transient increase of circulating ICOS(+)PD-1(+)CXCR3(+) T follicular helper (cTfh) cells in blood, which positively correlated with the induction of protective antibody responses measured at day 28. However, whether and how these T cells directly contribute to antibody response remains unclear. In this study, we analyzed the changes after TIV vaccination in the amount and the avidity of the polyclonal antibodies specific for the HA1 subunit of the pandemic H1N1 virus, and analyzed the correlation with the increase of ICOS(+)PD-1(+)CXCR3(+) cTfh cells. We found that both the amount and the avidity of specific antibodies rapidly increased during the first 7 days after TIV. Importantly, the increase of ICOS(+)PD-1(+)CXCR3(+) cTfh cells strongly correlated with the increase in the avidity of antibodies, particularly in subjects who did not have high affinity antibodies at baseline. We propose that ICOS(+)PD-1(+)CXCR3(+) Tfh cells directly contribute to the generation of high-avidity antibodies after TIV vaccinations by selectively interacting with high affinity B cells at extrafollicular sites. Nature Publishing Group 2016-05-27 /pmc/articles/PMC4882544/ /pubmed/27231124 http://dx.doi.org/10.1038/srep26494 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Bentebibel, Salah-Eddine Khurana, Surender Schmitt, Nathalie Kurup, Parvathi Mueller, Cynthia Obermoser, Gerlinde Palucka, A. Karolina Albrecht, Randy A. Garcia-Sastre, Adolfo Golding, Hana Ueno, Hideki ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination |
title | ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination |
title_full | ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination |
title_fullStr | ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination |
title_full_unstemmed | ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination |
title_short | ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination |
title_sort | icos(+)pd-1(+)cxcr3(+) t follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882544/ https://www.ncbi.nlm.nih.gov/pubmed/27231124 http://dx.doi.org/10.1038/srep26494 |
work_keys_str_mv | AT bentebibelsalaheddine icospd1cxcr3tfollicularhelpercellscontributetothegenerationofhighavidityantibodiesfollowinginfluenzavaccination AT khuranasurender icospd1cxcr3tfollicularhelpercellscontributetothegenerationofhighavidityantibodiesfollowinginfluenzavaccination AT schmittnathalie icospd1cxcr3tfollicularhelpercellscontributetothegenerationofhighavidityantibodiesfollowinginfluenzavaccination AT kurupparvathi icospd1cxcr3tfollicularhelpercellscontributetothegenerationofhighavidityantibodiesfollowinginfluenzavaccination AT muellercynthia icospd1cxcr3tfollicularhelpercellscontributetothegenerationofhighavidityantibodiesfollowinginfluenzavaccination AT obermosergerlinde icospd1cxcr3tfollicularhelpercellscontributetothegenerationofhighavidityantibodiesfollowinginfluenzavaccination AT paluckaakarolina icospd1cxcr3tfollicularhelpercellscontributetothegenerationofhighavidityantibodiesfollowinginfluenzavaccination AT albrechtrandya icospd1cxcr3tfollicularhelpercellscontributetothegenerationofhighavidityantibodiesfollowinginfluenzavaccination AT garciasastreadolfo icospd1cxcr3tfollicularhelpercellscontributetothegenerationofhighavidityantibodiesfollowinginfluenzavaccination AT goldinghana icospd1cxcr3tfollicularhelpercellscontributetothegenerationofhighavidityantibodiesfollowinginfluenzavaccination AT uenohideki icospd1cxcr3tfollicularhelpercellscontributetothegenerationofhighavidityantibodiesfollowinginfluenzavaccination |